Results 11 to 20 of about 137,949 (136)

Current perspectives on tree nut allergy: a review

open access: yesJournal of Asthma and Allergy, 2018
Tamar Weinberger, Scott Sicherer The Elliot and Roslyn Jaffe Food Allergy Institute, Division of Allergy and Immunology, Kravis Children’s Hospital, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA Abstract:
Weinberger T, Sicherer S
doaj   +1 more source

On the parameters of the Kerr-NUT-(anti-)de Sitter space-time [PDF]

open access: yes, 2007
Different forms of the metric for the Kerr–NUT–(anti-)de Sitter spacetime are being widely used in its extension to higher dimensions. The purpose of this note is to relate the parameters that are being used to the physical parameters (mass, rotation ...
J. Podolsky (7159979)   +1 more
core   +6 more sources

A study of cashew nut shell liquid purification and the synthesis of nonionic surfactants from the component phenols [PDF]

open access: yes, 1991
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University.The major phenolic lipids from natural and technical Cashew Nut-Shell Liquids were isolated by various techniques including precipitation, chemical ...
Bruce, Ian Edward
core   +7 more sources

Beyond labelling: What strategies do nut allergic individuals employ to make food choices? A qualitative study [PDF]

open access: yes, 2013
This article is made available through the Brunel Open Access Publishing Fund. Copyright @ 2013 Barnett et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use ...
Raats Monique M.   +28 more
core   +1 more source

Prospective genetic screening decreases the incidence of Abacavir hypersensitivity reactions in the Western Australian HIV cohort study [PDF]

open access: yes, 2005
Abacavir therapy is associated with significant drug hypersensitivity in ∼8% of recipients, with retrospective studies indicating a strong genetic association with the HLA-B*5701 allelle.
McKinnon, E.   +11 more
core   +2 more sources

The strategies that peanut and nut-allergic consumers employ to remain safe when travelling abroad [PDF]

open access: yes, 2012
Copyright @ 2012 Barnett et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use ...
Lucas Jane S   +16 more
core   +1 more source

Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life [PDF]

open access: yes, 2007
Background: prevalence and incidence of food hypersensitivity (FHS) and its trends in early childhood are unclear. Methods: a birth cohort born on the Isle of Wight (UK) between 2001 and 2002 was followed-up prospectively.
Grundy, J.   +22 more
core   +1 more source

Assessment of drug hypersensitivity with non-irritating concentrations of antibacterial agents for allergic skin tests: a review [PDF]

open access: yes, 2014
Hypersensitivity reactions to antibiotics are common with a prevalence of 6-10% of all adverse reactions. There is a lack of guidelines and standardization of skin tests for the screening of hypersensitivity to all antibiotics, in terms of the ...
M. C., Shivamurthy   +2 more
core   +1 more source

Urolithin A Modulates SIRT‐1 Mediated Improvement of Mitochondrial Health in Experimental Model of Oxaliplatin Induced Peripheral Neuropathy

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Oxaliplatin‐induced peripheral neuropathy (OIPN) is a major dose‐limiting adverse reaction of chemotherapy. It is characterised by motor and sensory hypersensitivity, loss of myelinated nerve fibres, oxidative stress, mitochondrial dysfunction and neuroinflammation.
Anubroto Pal   +8 more
wiley   +1 more source

Efficacy and Safety of Abatacept Versus Placebo During Peanut Oral Immunotherapy for Adults With Severe Peanut Allergy

open access: yesAllergy, EarlyView.
In this Phase 2a trial, severely peanut‐allergic participants were randomized to abatacept versus placebo with peanut oral immunotherapy (OIT) for 24 weeks, followed by 12 weeks of OIT alone. No significant difference was observed for the primary efficacy outcome (the relative change from baseline in peanut‐specific/total IgE ratio at 24 weeks), but ...
Marie‐Lee Simard   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy